• Company
• Tagrisso expands benefits as a first-line treatment
• by Mar 24, 2021 05:45am

• Policy
• CMOs tense up for a full day MFDS investigation
• by Lee, Tak-Sun Mar 23, 2021 06:24am

• Company
• Domestic approval of Ajovy is imminent
• by Eo, Yun-Ho Mar 23, 2021 06:24am

• Policy
• New benefits for Epidiolex will be established from April
• by Lee, Jeong-Hwan Mar 23, 2021 06:23am

• Policy
• “Regular COVID-19 vaccination like flu vaccination"
• by Kim, Jung-Ju Mar 23, 2021 06:23am

• Company
• Who’ll be the 2nd Korean-made COVID-19 drug?
• by Kim, Jin-Gu Mar 23, 2021 06:23am

• Policy
• The HIRA's reimbursed standards for chemotherapy are changed
• by Lee, Hye-Kyung Mar 23, 2021 06:23am

• Policy
• Pitavastatin-Ezetimibe by JW Pharmaceutical was applied
• by Lee, Tak-Sun Mar 22, 2021 06:18am

• Company
• Big 5 to prescribe a novel antifungal drug Cresemba
• by Eo, Yun-Ho Mar 22, 2021 06:17am

• Policy
• New standard for Adcetris combination has been established
• by Lee, Hye-Kyung Mar 22, 2021 06:17am